Skip to main content
Clinical Trials/NCT03720249
NCT03720249
Unknown
Not Applicable

Supplementation of Compound Nutrients on Plasma Homocysteine in Chinese Adults With Hyperhomocysteinemia: a Randomized Double-blind Control Trial

Huilian Zhu1 site in 1 country100 target enrollmentMay 20, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hyperhomocysteinemia
Sponsor
Huilian Zhu
Enrollment
100
Locations
1
Primary Endpoint
levels of homocysteine
Last Updated
6 years ago

Overview

Brief Summary

The purpose of this study is to determine whether supplementation of compound nutrients,including folic acid, vitamin B6, vitamin B12, betaine and zinc, will decrease the level of plasma homocysteine in Chinese adults with hyperhomocysteinemia.

Registry
clinicaltrials.gov
Start Date
May 20, 2019
End Date
December 31, 2022
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Huilian Zhu
Responsible Party
Sponsor Investigator
Principal Investigator

Huilian Zhu

professor

Sun Yat-sen University

Eligibility Criteria

Inclusion Criteria

  • People aged 18-65 years.
  • The level of plasma homocysteine is 15-100μmol/L.
  • Free from products which could decrease plasma homocysteine for at least one month.
  • Willing to participate in the study, consume the test product and perform all measurements.

Exclusion Criteria

  • pregnant or lactating women.
  • severe diseases need to control.
  • people who unconsciousness and can not complete questionnaire.
  • long-term regular use of vitamin or mineral supplements.

Outcomes

Primary Outcomes

levels of homocysteine

Time Frame: 12 weeks

At baseline, 4 weeks and 12 weeks, blood samples will be drawn and levels of homocysteine will be tested in two groups.

Secondary Outcomes

  • levels of 5-methyltetrahydrofolic acid, vitamin B6, vitamin B12 and betaine(12 weeks)
  • levels of s-adenosyl-methionine and s-adenosyl-homocysteine(12 weeks)
  • anthropomorphic measurements and blood biochemical markers(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials